Medical Health & Life Science Research News

Antibody drug conjugates market gains traction with new opportunities of expansion made available by top research firm

Antibody Drug Conjugates Market By Drugs (Adcetris And Kadcyla), Mechanism Of Action (CD30 Antibodies And HER2 Antibodies), Application (Breast Cancer And Lymphoma)

- Advertising -

The antibody drug conjugates market was valued at $1,387 million in 2016, and is estimated to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023. Antibody drug conjugates (ADC’s) are promising and effective anticancer medications employed for efficient treatment of cancer patients. ADC’s are biopharmaceutical drugs prepared by integrating two clinical approaches viz cell killing HPAPI (powerful pharmaceutical ingredient) and monoclonal antibody specificity.

This combination approach enables elimination of cancer infected cells without harming healthy cells in patient’s body.

- Advertising -

Request for Sample [email protected] www.researchbeam.com/antibody-drug…t/request-sample

Increase in global prevalence of cancer and demand for quality & cost-effective cancer medications drives the global ADCs market. In addition, extensive R&D for cancer medication and approval of new cancer drugs is expected to boost the market growth during the forecast period.

However, high cost involved in R&D of cancer medication and stringent government regulations impedes the growth of antibody drug conjugates market.

The report segments the market based on drugs, mechanism of action, application, and region. Based on drugs, the market is bifurcated into Adcetris and Kadcyla.

Based on mechanism of action, it is divided into CD30 antibodies and HER2 antibodies. Based on application, the market is classified into breast cancer, lymphoma, and others.

By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

For Report [email protected] www.researchbeam.com/antibody-drug…ire-about-report

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product elucidates the various types of ADC’s used for diverse cancer therapeutic procedures
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global ADCs market.

News From

Research Beam - precise market researchResearch Beam
Category: Market Research Publishers and RetailersCompany profile: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports fro ...